Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older

por Shiragami, Makoto, Mizukami, Akiko, Kaise, Toshihiko, Curran, Desmond, Van Oorschot, Desiree, Bracke, Benjamin, Watanabe, Daisuke
Publicado 2019

Public health impact model estimating the impact of introducing an adjuvanted recombinant zoster vaccine into the UK universal mass vaccination programme

por van Oorschot, Desirée A M, Hunjan, Manjit, Bracke, Benjamin, Lorenc, Stéphane, Curran, Desmond, Starkie-Camejo, Helen
Publicado 2019

Impact of respiratory syncytial virus disease on quality of life in adults aged ≥50 years: A qualitative patient experience cross‐sectional study

por Curran, Desmond, Cabrera, Eliazar Sabater, Bracke, Benjamin, Raymond, Kimberly, Foster, April, Umanzor, Cindy, Goulet, Philibert, Powers, John H.
Publicado 2022

Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer

por Verhoek, Andre, Cheema, Parneet, Melosky, Barbara, Samson, Benoit, Shepherd, Frances A., de Marinis, Filippo, John, Thomas, Wu, Yi-Long, Heeg, Bart, Van Dalfsen, Nadia, Bracke, Benjamin, Miranda, Miguel, Shaw, Simon, Moldaver, Daniel
Publicado 2023